ITGB3 and prostate cancer: In good accordance, it has been shown that transmembranous shifting of the integrin subtype β1 (ITGB1) may contribute to metastatic progression of bladder cancer cells [21], and ITGB3 translocation has been associated with adhesive behaviour in prostate cancer cells [22].